Nutech Formulations Private Limited
About Nutech Formulations Private Limited
Data last updated:
Nutech Formulations Private Limited is a private limited company based in New Delhi, Delhi, India. It operates in the manufacturing segment of the healthcare sector. It was incorporated on 17 October 1996 and has been in existence for over 30 years.
The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U33100DL1996PTC082734.
The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹9.17 Lakh. It is led by directors Neena Tandon (Whole-Time Director) and Atul Prakash Tandon (Whole-Time Director).
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Dg – 111/86 Vikas Puri, New Delhi, Delhi, India – 110018.
As per the financials filed for FY 2025, the company reported a revenue of ₹42,346, a growth of 5% compared to the previous year. For the same year it recorded a net profit of ₹1,103 (net margin 2.6%) and EBITDA of ₹1,347 (EBITDA margin 3.2%). Revenue has grown at a compounded annual rate (CAGR) of 4% over three years and 3% over five years.
The current compliance status is marked as compliant by the Registrar of Companies.
Company details
Contact details
Nutech Formulations Private Limited's registered office is in New Delhi, Delhi. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered AddressDg – 111/86 Vikas Puri, New Delhi, Delhi, India – 110018
- IndustryHealthcare, Manufacturing, Medical Appliances And Instruments
To see the full contact details of Nutech Formulations Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Financials of Nutech Formulations Private Limited
FY 2025 filings availableNutech Formulations Private Limited reported revenue of ₹42,346 (up 5% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue has grown at a compounded annual rate (CAGR) of 3% over five years, including 5% growth in the latest year. EBITDA fell 63% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹1,347 | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹1,103 | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 3.2% | ||||
| Net Profit Margin | 2.6% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Nutech Formulations Private Limited, buy the company report.
Board of directors of Nutech Formulations Private Limited
Nutech Formulations has 2 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Neena Tandon Also directs: Hallmark Hospitals Private Limited | Whole-Time Director | 24 Feb 2004 | 22 Years 8 Months | Current |
| Atul Prakash Tandon Also directs: Hallmark Hospitals Private Limited | Whole-Time Director | 01 Nov 1996 | 29 Years 11 Months | Current |
Peer comparison
Nutech Formulations Private Limited is compared with the 10 companies closest to it by revenue in the Pharma industry (Formulations), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Goodhealth Holdings Private Limited | ₹44,000 (FY 2025) | Chennai, Tamil Nadu, India | ||||
| Ultimed Pharma Private Limited | ₹43,503 (FY 2021) | -92.0% | Mumbai, Maharashtra, India | |||
| DBS Pharma Private Limited | ₹42,900 (FY 2024) | -100.0% | Hyderabad, Telangana, India | |||
| Alpa Expoim Private Limited | ₹42,390 (FY 2021) | New Delhi, Delhi, India | ||||
| Phages Pharmaceutical Private Limited | ₹42,360 (FY 2024) | 20.0% | Prayagraj, Uttar Pradesh, India | |||
| Nutech Formulations Private Limitedthis company | ₹42,346 (FY 2025) | ₹1,103 | 2.6% | 5.0% | New Delhi, Delhi, India | |
| Protent Pharma Private Limited | ₹42,119 (FY 2025) | -3.0% | Mrg, Uttar Pradesh, India | |||
| Genesis Labs Limited | ₹42,006 (FY 2025) | 1100.0% | Mumbai, Maharashtra, India | |||
| Winsome Laboratories Limited | ₹41,916 (FY 2025) | 5.0% | Delhi, India | |||
| Harson Labs Pvt Ltd | ₹41,378 (FY 2025) | -98.0% | Vadodara, Gujarat, India | |||
| Vyome Biosciences Private Limited | ₹40,161 (FY 2025) | -96.0% | Vadodara, Gujarat, India |
To see the full peer comparison of Nutech Formulations Private Limited, buy the company report.
Auditor
Nutech Formulations Private Limited is audited by RAHUL MEHROTRA & ASSOCIATES for the financial year 2017.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| RAHUL MEHROTRA & ASSOCIATES | FY 2017 | 012375C |
Shareholding
The shareholding of Nutech Formulations Private Limited is on record for 2 financial years, the latest being FY 2017, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2017 | FY 2016 |
|---|---|---|
| Promoters | ||
| Domestic institutional investors (DII) | ||
| Foreign institutional investors (FII) | ||
| Public | ||
| Others |
To see the full shareholding pattern of Nutech Formulations Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Nutech Formulations Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Nutech Formulations Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
No GST registration is on our record for Nutech Formulations Private Limited; the GSTIN and return-filing check is in the company report Buy the company report.
Recent activity
Nutech Formulations Private Limited has 2 board changes on record since 1996: 2 appointments. The latest: Neena Tandon was appointed as Whole-Time Director on 24 Feb 2004.
Frequently asked questions
Nutech Formulations is an active private limited company based in New Delhi, Delhi, India. The company works in manufacturing, within the healthcare industry. It was incorporated on 17 October 1996 (30+ years old) and is registered under CIN U33100DL1996PTC082734.
Nutech Formulations has 2 current directors:
- Neena Tandon - Whole-Time Director
- Atul Prakash Tandon - Whole-Time Director
The latest financial statements of Nutech Formulations on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.
The CIN (Corporate Identification Number) of Nutech Formulations is U33100DL1996PTC082734. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Nutech Formulations was incorporated on 17 October 1996, making it 30+ years old. It is registered with the Registrar of Companies, Delhi.
The peers of Nutech Formulations by revenue are Goodhealth Holdings Private Limited, Ultimed Pharma Private Limited, DBS Pharma Private Limited, Alpa Expoim Private Limited, Phages Pharmaceutical Private Limited and 5 more, all in the Pharma industry (Formulations).
Neena Tandon was appointed as Whole-Time Director on 24 Feb 2004. Atul Prakash Tandon was appointed as Whole-Time Director on 01 Nov 1996.
The registered office of Nutech Formulations is at Dg – 11186 Vikas Puri, New Delhi, Delhi, India – 110018.
Nutech Formulations operates in the healthcare industry, in the manufacturing segment.
The compliance status of Nutech Formulations is compliant as of 28 July 2026. The company is actively filing with the Registrar of Companies.
Nutech Formulations can be reached at its registered office: Dg – 11186 Vikas Puri, New Delhi, Delhi, India – 110018.